Systemic inflammation markers and cancer incidence in the UK Biobank

[1]  J. Witte,et al.  Integration of polygenic risk scores with modifiable risk factors improves risk prediction: results from a pan-cancer analysis , 2020 .

[2]  J. Witte,et al.  Pan-cancer analysis demonstrates that integrating polygenic risk scores with modifiable risk factors improves risk prediction , 2020, Nature Communications.

[3]  P. Elliott,et al.  White Blood Cell Count and Risk of Incident Lung Cancer in the UK Biobank. , 2019, JNCI cancer spectrum.

[4]  B. Stricker,et al.  The systemic immune‐inflammation index is associated with an increased risk of incident cancer—A population‐based cohort study , 2019, International journal of cancer.

[5]  Jingting Jiang,et al.  Scoring System for Tumor-Infiltrating Lymphocytes and Its Prognostic Value for Gastric Cancer , 2019, Front. Immunol..

[6]  Wan-Hai Wang,et al.  Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis , 2018, Journal of Cancer.

[7]  L. Di,et al.  Immunogenomic Analyses of Advanced Serous Ovarian Cancer Reveal Immune Score is a Strong Prognostic Factor and an Indicator of Chemosensitivity , 2018, Clinical Cancer Research.

[8]  T. Wagner,et al.  The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis , 2018, Front. Oncol..

[9]  D. McMillan,et al.  The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis , 2017, Scientific Reports.

[10]  F. Pezzella,et al.  Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  T. Nielsen,et al.  The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  S. Clarke,et al.  Cancer-related inflammation and treatment effectiveness. , 2014, The Lancet. Oncology.

[13]  W. Guo,et al.  Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma , 2014, Clinical Cancer Research.

[14]  F. Marincola,et al.  Cancer classification using the Immunoscore: a worldwide task force , 2012, Journal of Translational Medicine.

[15]  R. Collins.  What makes UK Biobank special? , 2012, The Lancet.

[16]  B. Nordestgaard,et al.  Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer , 2011, Critical reviews in clinical laboratory sciences.

[17]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[18]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[19]  Paul C. Lambert,et al.  Further Development of Flexible Parametric Models for Survival Analysis , 2009 .

[20]  Alberto Mantovani,et al.  Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.

[21]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[22]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.